SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-086410
Filing Date
2023-11-14
Accepted
2023-11-14 07:14:35
Documents
14
Period of Report
2023-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea188340-8k_biomx.htm   iXBRL 8-K 35876
2 PRESS RELEASE DATED NOVEMBER 14, 2023 ea188340ex99-1_biomx.htm EX-99.1 84107
  Complete submission text file 0001213900-23-086410.txt   352283

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE phge-20231114.xsd EX-101.SCH 3919
4 XBRL DEFINITION FILE phge-20231114_def.xml EX-101.DEF 26852
5 XBRL LABEL FILE phge-20231114_lab.xml EX-101.LAB 37192
6 XBRL PRESENTATION FILE phge-20231114_pre.xml EX-101.PRE 25476
8 EXTRACTED XBRL INSTANCE DOCUMENT ea188340-8k_biomx_htm.xml XML 5709
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 231401555
SIC: 2836 Biological Products, (No Diagnostic Substances)